US Patent Issued to Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical on March 25 for "IL-5 antibody, antigen binding fragment thereof, and medical application therefor" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,394, issued on March 25, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai).

"IL-5 antibody, antigen binding fragment thereof, and medical application therefor" was invented by Hua Ying (Shanghai), Jinping Shi (Shanghai), Yifang Wang (Shanghai), Qiyue Hu (Shanghai), Hu Ge (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an IL-5 antibody, an antigen binding fragment thereof, and a medical application therefor. The present invention comprises a mouse-derived antibody containing an IL-5 antibody CDR region, a chimeric antibody, a...